In lat­est set­back, an­oth­er Co­herus part­ner bails out on Am­gen biosim­i­lar deal

Just days af­ter Co­herus $CHRS was forced to re­struc­ture and lay off 51 staffers in the wake of the FDA’s de­ci­sion to re­ject its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.